BRD4 inhibitors block telomere elongation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Cancer cells maintain telomere length equilibrium to avoid senescence and apoptosis induced by short telomeres, which trigger the DNA damage response. Limiting the potential for telomere maintenance in cancer cells has been long been proposed as a therapeutic target. Using an unbiased shRNA screen targeting known kinases, we identified bromodomain-containing protein 4 (BRD4) as a telomere length regulator. Four independent BRD4 inhibitors blocked telomere elongation, in a dose-dependent manner, in mouse cells overexpressing telomerase. Long-term treatment with BRD4 inhibitors caused telomere shortening in both mouse and human cells, suggesting BRD4 plays a role in telomere maintenance in vivo. Telomerase enzymatic activity was not directly affected by BRD4 inhibition. BRD4 is in clinical trials for a number of cancers, but its effects on telomere maintenance have not been previously investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, BRD4 was shown to positively regulate telomere elongation in murine and human cultures105.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationSelective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 11×
“JQ1 (Selleckchem S7110), OTX015 (Selleckchem S7360), I-BET151 (Selleckchem S2780), and MS436 (Selleckchem S7305) were used to inhibit BRD4.”
BackgroundInfluentialIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase elongates telomeres and maintains a telomere length equilibrium that prevents telomeres from becoming critically short (5).”
BackgroundSelf-citationA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684 · cited 7×
“Bioinformatic analysis Illumina reads were aligned to reference sequences using Bowtie2 as described (42,43), and enriched genes were determined by evaluating 3 biological replicates with MAGeCK analysis (44).”
MethodInfluentialTargeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 1×
“BRD4 translocations are linked to cancer, and BRD4 inhibition reduces cell proliferation in acute myeloid leukemia (63,64), potentially by blocking BRD4 mediated transcription of c-MYC.”
BackgroundHighly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
How Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 1×
“Indeed, germline mutations in the TERT promoter, or POT1, predispose to familial melanoma, glioma or CLL respectively (13-15).”
BackgroundSuppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 1×
“BRD4 also affects immune cell function through its interaction with NF- B (68), and BRD4 inhibitors have been proposed as anti-inflammatory agents, including in liver fibrosis and idiopathic pulmonary fibrosis (69,70).”
BackgroundKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Self-citationTargeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,243
Hemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Self-citationTargeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · cited 1×
“However, these approaches should be carefully considered, because short telomeres in humans lead to Telomere Syndromes that can manifest as bone marrow failure, pulmonary fibrosis, liver fibrosis, and other disease (67-69).”
BackgroundRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798
Control of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768 · cited 1×
“Telomere elongation is regulated by shelterin proteins (28-30) and by post-translational”
BackgroundTelomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728 · cited 1×
“Imtelstat is an effective in vitro telomerase inhibitor and it shortens telomeres in human cultured cells (21,22).”
BackgroundThe POT1-TPP1 telomere complex is a telomerase processivity factor.
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R., & Lei, M. (2007) · Nature · doi:10.1038/nature05454 · Cited by 704
The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation
Wu, S.-Y., & Chiang, C.-M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700001200 · Cited by 679
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529
Telomerase activity in normal leukocytes and in hematologic malignancies
Counter, C., Gupta, J., Harley, C., Leber, B., & Bacchetti, S. (1995) · Blood · doi:10.1182/blood.v85.9.2315.bloodjournal8592315 · Cited by 477
Armanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452 · cited 1×
“In the setting of insufficient telomerase or other telomere gene mutations in humans, short telomere syndromes manifest as bone marrow failure, immunodeficiency, enteropathy, pulmonary fibrosis and emphysema (6,7).”
BackgroundSelf-citationFlow cytometry and FISH to measure the average length of telomeres (flow FISH)
Baerlocher, G. M., Vulto, I., de Jong, G., & Lansdorp, P. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.263 · Cited by 449 · cited 3×
“We adapted a flowFISH protocol (40) to hybridize telomere probe to telomeres, in intact cells, and then separate cells based on telomere length, using fluorescence activated cell sorting (FACS).”
MethodInfluentialTelomerase Activity in Human Breast Tumors
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.116 · Cited by 423
A highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Berthon, C., Raffoux, E., Thomas, X., Vey, N., Gomez-Roca, C., Yee, K., Taussig, D. C., Rezai, K., Roumier, C., Herait, P., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00247-1 · Cited by 420
Amorim, S., Stathis, A., Gleeson, M., Iyengar, S., Magarotto, V., Leleu, X., Morschhauser, F., Karlin, L., Broussais, F., Rezai, K., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)00021-1 · Cited by 417
Telomerase, Cell Immortality, and Cancer
Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.035 · Cited by 396
Self-citationGreenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaier, B., & Petes, T. D. (1995) · Cell · doi:10.1016/0092-8674(95)90479-4 · Cited by 385
Devaiah, B. N., Lewis, B. A., Cherman, N., Hewitt, M. C., Albrecht, B. K., Robey, P. G., Ozato, K., Sims, R. J., & Singer, D. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120422109 · Cited by 378
BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
Devaiah, B. N., Case-Borden, C., Gegonne, A., Hsu, C. H., Chen, Q., Meerzaman, D., Dey, A., Ozato, K., & Singer, D. S. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3228 · Cited by 361
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity
Nandakumar, J., Bell, C. F., Weidenfeld, I., Zaug, A. J., Leinwand, L. A., & Cech, T. R. (2012) · Nature · doi:10.1038/nature11648 · Cited by 352
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201266200 · Cited by 326
Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
Dey, A., Nishiyama, A., Karpova, T., McNally, J., & Ozato, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0380 · Cited by 316
Telomere length homeostasis requires that telomerase levels are limiting
Cristofari, G., & Lingner, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600952 · Cited by 314
Understanding TERT Promoter Mutations: A Common Path to Immortality
Bell, R. J. A., Rube, H. T., Xavier-Magalhães, A., Costa, B. M., Mancini, A., Song, J. S., & Costello, J. F. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0003 · Cited by 307
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
Ramsay, A. J., Quesada, V., Foronda, M., Conde, L., Martínez-Trillos, A., Villamor, N., Rodríguez, D., Kwarciak, A., Garabaya, C., Gallardo, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2584 · Cited by 276
Telomeres, telomerase and senescence
Greider, C. W. (1990) · BioEssays · doi:10.1002/bies.950120803 · Cited by 266
Self-citationGene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation
Zhao, R., Nakamura, T., Fu, Y., Lazar, Z., & Spector, D. L. (2011) · Nature Cell Biology · doi:10.1038/ncb2341 · Cited by 253
BRD4 is a novel therapeutic target for liver fibrosis
Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211 · cited 1×
“BRD4 also affects immune cell function through its interaction with NF- B (68), and BRD4 inhibitors have been proposed as anti-inflammatory agents, including in liver fibrosis and idiopathic pulmonary fibrosis (69,70).”
BackgroundBRD4 Bromodomain Gene Rearrangement in Aggressive Carcinoma with Translocation t(15;19)
French, C. A., Miyoshi, I., Aster, J. C., Kubonishi, I., Kroll, T. G., Dal Cin, P., Vargas, S. O., Perez-Atayde, A. R., & Fletcher, J. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63049-0 · Cited by 206
POT1–TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation
Latrick, C. M., & Cech, T. R. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.409 · Cited by 188
Short Telomeres Induce a DNA Damage Response in Saccharomyces cerevisiae
IJpma, A. S., & Greider, C. W. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-04-0057 · Cited by 178
Self-citationChiappori, A. A., Kolevska, T., Spigel, D. R., Hager, S., Rarick, M., Gadgeel, S., Blais, N., Von Pawel, J., Hart, L., Reck, M., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu550 · Cited by 178
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
Eldaly, H., Kull, M., Zimmermann, S., Pantić, M., Waller, C. F., & Martens, U. M. (2004) · Blood · doi:10.1182/blood-2003-12-4322 · Cited by 171
Chaidos, A., Caputo, V., & Karadimitris, A. (2015) · Therapeutic Advances in Hematology · doi:10.1177/2040620715576662 · Cited by 164
ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres
Tong, A. S., Stern, J. L., Sfeir, A., Kartawinata, M., de Lange, T., Zhu, X.-D., & Bryan, T. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.041 · Cited by 142
Vodenicharov, M. D., & Wellinger, R. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.035 · Cited by 139
Bromodomain 4: a cellular Swiss army knife
Devaiah, B. N., Gégonne, A., & Singer, D. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0616-250r · Cited by 136
Enomoto, S., Glowczewski, L., & Berman, J. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0012 · Cited by 133
Tang, X., Peng, R., Phillips, J. E., Deguzman, J., Ren, Y., Apparsundaram, S., Luo, Q., Bauer, C. M. T., Fuentes, M. E., DeMartino, J. A., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.020 · Cited by 128
Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Röth, A., Harley, C. B., & Baerlocher, G. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_16 · Cited by 126
The short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 124
Regulation of Telomere Elongation by the Cyclin-Dependent Kinase CDK1
Frank, C. J., Hyde, M., & Greider, C. W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.020 · Cited by 112
Self-citationATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells
Lee, S. S., Bohrson, C., Pike, A. M., Wheelan, S. J., & Greider, C. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.035 · Cited by 106
Self-citationTelomerase activation: one step on the road to cancer?
Greider, C. W. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01681-3 · Cited by 99
Self-citationDNA-damage response and repair activities at uncapped telomeres depend on RNF8
Peuscher, M. H., & Jacobs, J. J. L. (2011) · Nature Cell Biology · doi:10.1038/ncb2326 · Cited by 77
Short Telomeres Initiate Telomere Recombination in Primary and Tumor Cells
Morrish, T. A., & Greider, C. W. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000357 · Cited by 73
Self-citationHigh-Throughput RNAi Screening Reveals Novel Regulators of Telomerase
Cerone, M. A., Burgess, D. J., Naceur-Lombardelli, C., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2734 · Cited by 48
Coussens, M., Davy, P., Brown, L., Foster, C., Andrews, W. H., Nagata, M., & Allsopp, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913834107 · Cited by 43
Strezoska, Ž., Licon, A., Haimes, J., Spayd, K. J., Patel, K. M., Sullivan, K., Jastrzebski, K., Simpson, K. J., Leake, D., van Brabant Smith, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042341 · Cited by 38
Treating Myeloproliferation — On Target or Off?
Armanios, M. Y., & Greider, C. W. (2015) · New England Journal of Medicine · doi:10.1056/nejme1508740 · Cited by 38
Self-citationA Yeast Chemical Genetic Screen Identifies Inhibitors of Human Telomerase
Wong, L. H., Unciti‐Broceta, A., Spitzer, M., White, R., Tyers, M., & Harrington, L. A. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.008 · Cited by 28
Telomeres, telomerase and cancer: is the magic bullet real?
Hw, S., MALTÉSE, J. ‐., Zhu, X., Kaiser, H. E., & Narayanan, R. (1996) · PubMed · Cited by 28
An Overview on Small Molecule Inhibitors of BRD4
Huang, W., Zheng, X., Yang, Y., Wang, X., & Shen, Z. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160611014130 · Cited by 27
Genomic instability in�both wild-type and telomerase null MEFs
Hao, L.-Y., & Greider, C. W. (2004) · Chromosoma · doi:10.1007/s00412-004-0291-7 · Cited by 9
Self-citation
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
BRD4 and Cancer: going beyond transcriptional regulation
Donati, B., Lorenzini, E., & Ciarrocchi, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0915-9 · Cited by 708
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Yang, J., Xu, J., Wang, W., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 388
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy
Chelladurai, P., Boucherat, O., Stenmark, K. R., Kracht, M., Seeger, W., Bauer, U., Bonnet, S., & Pullamsetti, S. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14932 · Cited by 123
BET proteins: Biological functions and therapeutic interventions
Guo, J., Zheng, Q., & Peng, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108354 · Cited by 98
Metadata
- Authors
- Wang, S., Pike, A. M., Lee, S. S., Strong, M. A., Connelly, C. J., & Greider, C. W.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Greider, Carol W.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-30
- Volume
- 45
- Issue
- 14
- Pages
- 8403-8410
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5737673
- OpenAlex
- W2949192443
- Cited by
- 45
- References
- 74
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 2 · 2017: 1
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- University of California, Riverside
- National Cancer Institute (R01CA160300)
- National Institute of General Medical Sciences (T32GM008752)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- BRD4, bromodomain proteins, telomere maintenance, telomere elongation, telomerase, telomere shortening, cancer therapy, shRNA screen, kinases, DNA damage response, cellular senescence
- MeSH terms
- Acetanilides, Bromodomain Containing Proteins, Animals, Azepines, Cell Line, Dose-Response Relationship, Drug, Fibroblasts, HeLa Cells, Heterocyclic Compounds, 3-Ring, Heterocyclic Compounds, 4 or More Rings, Humans, Morpholines, Nuclear Proteins, Pyrones, Transcription Factors, Triazoles, Blotting, Southern, Gene Expression, Telomere, In Situ Hybridization, Fluorescence, Cell Cycle Proteins, Telomerase, RNA Interference, Mice, Telomere Homeostasis, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.